Cognizant beats Q1 revenue estimates on large deals in health sciences, financial services

featured-image

Revenue came in at $5.1 billion, up 7.5 percent or 8.

2 percent in constant currency, form the year-ago period. Subsidiaries Belcan and Thirdera contributed approximately 400 basis points to revenue growth.